Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Contradictory Relationships between Cancer and Normal Cells and Implications for Anti-cancer Therapy

  • Gou, Xing-Chun (Institute of Basic Medical Science & Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Xi'an Medical University) ;
  • Kong, Derek (Yale School of Medicine, Yale University) ;
  • Tang, Xu (Department of Pathology, Sichuan College of Traditional Chinese Medicine)
  • Published : 2015.08.03
Download PDF
⟨ Previous Next ⟩

Abstract

Cancer treatment remains a serious problem worldwide. Analysis of the relationship between cancer cells and normal cells reveals that these two share characteristics in contradiction, thus could be analyzed by using contradictory principles. Under the theory of contradictory principles, induction of a dormant state or reversal of cancer cells is an important treatment strategy beyond traditional cytotoxic therapy. Normal cells are also the targets and under the influence of anti-cancer treatments and should be considered during therapy. Findings based on crosstalk between these two cell types may offer opportunities for the development of new biomarkers and therapies.

Keywords

References

  1. Brinton LT, Sloane HS, Kester M, et al (2015). Formation and role of exosomes in cancer. Cell Mol Life Sci, 72, 659-71. https://doi.org/10.1007/s00018-014-1764-3
  2. Chen L, Du J, Dai Q, et al (2014). Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking. Eur J Med Chem, 83, 294-306. https://doi.org/10.1016/j.ejmech.2014.06.037
  3. Chen Y, GouX, Ke X, et al (2012). Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I. PLoS One, 7, 40965. https://doi.org/10.1371/journal.pone.0040965
  4. Chung AS, Kowanetz M, Wu X, et al (2012). Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors. J Pathol, 227, 404-16. https://doi.org/10.1002/path.4052
  5. Ding C, Zhang C, Zhang M, et al (2014). Multitarget inhibitors derived from crosstalk mechanism involving VEGFR2. Future Med Chem, 6, 1771-89. https://doi.org/10.4155/fmc.14.112
  6. Gammons MV, Lucas R, Dean R, et al (2014). Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma. Br J Cancer, 111, 477-85. https://doi.org/10.1038/bjc.2014.342
  7. Gatenby RA (2009). A change of strategy in the war on cancer. Nature, 459, 508-9. https://doi.org/10.1038/459508a
  8. Hensel JA, Flaig TW, Theodorescu D (2013). Clinical opportunities and challenges in targeting tumour dormancy. Nat Rev Clin Oncol, 10, 41-51.
  9. Hu H, Qiu Y, Guo M, et al (2015). Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models. Oncotarget, 6, 1079-89. https://doi.org/10.18632/oncotarget.2835
  10. Ji DB, Ye J, Jiang YM, et al (2009). Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice. BMC Complement Altern Med, 9, 20. https://doi.org/10.1186/1472-6882-9-20
  11. Johnson LM, Price DK, Figg WD (2013). Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment. Cancer Biol Ther, 14, 90-91. https://doi.org/10.4161/cbt.22636
  12. Kahlert C, Kalluri R (2013). Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl), 91, 431-7. https://doi.org/10.1007/s00109-013-1020-6
  13. Ke X, Fei F, Chen Y, et al (2012). Hypoxia upregulates CD147 through a combined effect of HIF-1alpha and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis, 33, 1598-607. https://doi.org/10.1093/carcin/bgs196
  14. Kidher E, Cheng Z, Jarral OA, et al (2014). In-vivo assessment of the morphology and hemodynamic functions of the BioValsalva composite valve-conduit graft using cardiac magnetic resonance imaging and computational modelling technology. J Cardiothorac Surg, 9, 193. https://doi.org/10.1186/s13019-014-0193-6
  15. Kwilas AR, Ardiani A, Donahue RN, et al (2014). Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine. J Transl Med, 12, 294. https://doi.org/10.1186/s12967-014-0294-y
  16. Lavi O, Skinner J, Gottesman MM (2014). Network features suggest new hepatocellular carcinoma treatment strategies. BMC Syst Biol, 8, 88. https://doi.org/10.1186/s12918-014-0088-0
  17. Mavrou A, Brakspear K, Hamdollah-Zadeh M, et al (2014). Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene.
  18. Melo SA, Sugimoto H, O'Connell JT, et al (2014). Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell, 26, 707-21. https://doi.org/10.1016/j.ccell.2014.09.005
  19. Pavelic J (2014). Editorial: combined cancer therapy. Curr Pharm Des, 20, 6511-2. https://doi.org/10.2174/1381612820666140826154834
  20. Prescott EL, Brimacombe CL, Hartley M, et al (2014). Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2. J Virol, 88, 12599-611. https://doi.org/10.1128/JVI.02029-14
  21. Shand LK, Cowlishaw S, Brooker JE, et al (2014). Correlates of post-traumatic stress symptoms and growth in cancer patients: a systematic review and meta-analysis. Psychooncology, 24, 624-34.
  22. Sim BY, Lee YW, Kim H, et al (2014). Post-traumatic growth in stomach cancer survivors: Prevalence, correlates and relationship with health-related quality of life. Eur J Oncol Nurs.
  23. Sun Y, Campisi J, Higano C, et al (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med, 18, 1359-68. https://doi.org/10.1038/nm.2890
  24. Tang Y, Kesavan P, Nakada MT, et al (2004). Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res, 2, 73-80.
  25. Wojtowicz-Praga S (1997). Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother, 20, 165-177. https://doi.org/10.1097/00002371-199705000-00001
  26. Xia Q, Mao W (2014). Anti-tumor effects of traditional Chinese medicine give a promising perspective. J Cancer Res Ther, 10, 1-2.
  27. Yin Q, Shen J, Zhang Z, et al (2013). Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv Drug Deliv Rev, 65, 1699-715. https://doi.org/10.1016/j.addr.2013.04.011
  28. Zhai B, Sun XY (2013). Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma. World J Hepatol, 5, 345-52. https://doi.org/10.4254/wjh.v5.i7.345